GMP CMV Antijen Üretimi Türkiye

• 

  Hastalık Önlemenin Geliştirilmesi İçin GMP CMV Antijen Üretimindeki Gelişmeler

  Aşı ve tedaviler yaratma konusunda araştırma, deney ve yenilik yapmaya devam ederken, Yaohai'nin ürünleri de GMP Anti-PD-1PD-L1 VHH. Additional, we are working hard on developing new tools and technologies to enable us to design personalized therapies for patients. We are looking at some incredible new immuno therapies that have the potential to make life saving impacts and revolutionise the treatment of many diseases.

• 

  Yüksek Kaliteli ve Tutarlı Biyolojik Ürünler Sunuyoruz

  Biyoterapötikler veya canlı hücrelerden elde edilen ilaçlar çok karmaşık ürünlerdir ve her partinin aynı olduğundan ve çok yüksek kalite standartlarını karşıladığından emin olmak için sıkı kurallar altında üretilmelidir. Yaohai'de, her seferinde en yüksek kalitede ilaçlar üretmemizi sağlayan son teknoloji ve üretim çözümleri sunmaya çalışıyoruz; GMP uygulamalarımızın devreye girdiği yer burasıdır. Ürettiğimiz her ilaç partisinin, ihtiyaç duyulduğunda kullanılabilecek kadar saf ve güçlü olduğundan emin oluruz. VLP Kanser Aşısı Üretimi Yaohai'den.

• 

  Kişiselleştirilmiş Sağlık Bakım Çözümleri için GMP CMV Antijen Üretimi

  Kişiselleştirilmiş sağlık hizmeti kavramı, her hastanın genleri, farmakogenetik profili (bir kişinin genetik bilgilerine göre ilaçları nasıl işlediğini gösteren profil) vb. kullanılarak tasarlanan tedavilerle ilgili bir yenilik olarak başladı, tıpkı Yaohai'ninki gibi VLP Üretimi için E. coli Fermantasyonu. GMP makes it possible for us to generate personalized immuno therapies that will help combat these major diseases.

Neden Yaohai GMP CMV Antigen Manufacturing'i seçmelisiniz?

• Mesleki Uzmanlık ve Kapsamlı Deneyim

  Yaohai Bio-Pharma is a leading microbial biologics CDMO. Our main focus has been the production of GMP CMV Antigen Manufacturing and therapeutics to treat pets, human and veterinary health. We have state-of-the-art RD platforms and manufacturing technology that cover the entire manufacturing process beginning with the development of microbial strains Cell banking, process and method development, through commercial and clinical manufacture that ensures the successful delivery of innovative solutions. Over time we've gained a vast knowledge of microbial-based bio processing. We have successfully completed more than 200 global projects, and help our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react promptly to market demands and provide tailored CDMO services due to our experience and expertise.

• Kalite Sistemi ve Küresel Mevzuata Uygunluk

  GMP CMV Antigen Manufacturing is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have established a robust quality system that complies with the current GMP standards and regulations all over the world. Our regulatory team is well-versed on global regulatory frameworks to speed up biological launches. We guarantee traceable production processes and top-quality products that are compliant with the rules of US FDA, EU EMA, Australia TGA, and China NMPA. Yaohai BioPharma successfully passed an audit on site conducted by an accredited Qualified Person from the European Union (QP) to review our GMP system and production facility. Additionally, we've passed the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Kişiselleştirme, Verimlilik ve Maliyet Verimliliği

  Yaohai Bio-Pharma is GMP CMV Antigen Manufacturing in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.

• Güçlü Tedarik Zinciri ve Üretim Yetenekleri

  Yaohai Bio-Pharma, a top 10 GMP CMV Antigen Manufacturing of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

İlgili ürün kategorileri

• AAV Plazmit Üretimi
• Plazmid DNA için Analitik Yöntemler
• Bakteriyofaj AP205 VLP İmalatı
• Bakteriyofaj Q VLP Üretimi
• Kimerik VLP Aşı Üretimi
• Konjuge VLP Aşıları İmalatı
• DNA Aşısı Üretimi
• VLP Üretimi için E. coli Fermantasyonu
• GLP-1 Agonist Üretimi
• GLP-1 Analog Üretim

Aradığınızı bulamıyor musunuz?
Daha fazla mevcut ürün için danışmanlarımızla iletişime geçin.